Privigen 10% vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFBQ4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,362
Award facts
- Contract value 100% obligated
- $52,362.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $52,362 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Privigen 10% intravenous immunoglobulin in 200mL vials. This delivery order, issued on December 9, 2025, with an ultimate completion date of December 31, 2025, was placed without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award represents one of numerous delivery orders issued to DMS Pharmaceutical Group under its broader Indefinite Delivery Contract with the Defense Logistics Agency.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract designated SPE2DR, established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative awarded on November 13, 2025. The underlying contract, valued at $500 million with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional pharmaceutical supplier supporting Department of Defense military healthcare facilities worldwide. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to streamline pharmaceutical procurement and ensure reliable access to branded pharmaceuticals, generic medications, biologics, and specialized medical consumables across the global military medical system. As a prime vendor contractor, DMS Pharmaceutical Group demonstrates established performance in supplying diverse pharmaceutical products ranging from oncology treatments and immunosuppressants to emergency medications and routine pharmaceuticals essential to military medical operations.
Quick answers
Who was awarded contract SPE2DR26FFBQ4?
SPE2DR26FFBQ4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FFBQ4 worth?
The government has obligated $52,362 on SPE2DR26FFBQ4.
Is contract SPE2DR26FFBQ4 an order under another contract?
Yes. SPE2DR26FFBQ4 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBQ4 competed?
The extent of competition for SPE2DR26FFBQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award